Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MT.DERM is a Germany-based medical technology and aesthetics device company focused on the development and manufacture of devices used to introduce pigments and other substances into the skin. The company operates across cosmetic, medical, and tattoo applications, with core activities in microneedling, micropigmentation, permanent makeup, and professional tattoo equipment. Its products are marketed through brands including amiea, amiea med, Cheyenne, and VYTAL, and the company manufactures in Germany under ISO 13485-certified quality systems. MT.DERM appears to be a commercial-stage device business rather than a therapeutics developer, with revenues generated from device systems, cartridges, accessories, and related skin-treatment products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MT.DERM.